143 related articles for article (PubMed ID: 22137848)
1. Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors.
Tian X; Wang LY; Xia S; Li ZB; Liu XH; Yuan Y; Fang L; Zuo H
Bioorg Med Chem Lett; 2012 Jan; 22(1):204-6. PubMed ID: 22137848
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazines.
Ihmaid SK; Al-Rawi JM; Bradley CJ; Angove MJ; Robertson MN
Eur J Med Chem; 2012 Nov; 57():85-101. PubMed ID: 23059543
[TBL] [Abstract][Full Text] [Related]
3. The synthesis of 4,7-disubstituted-2H-benzo[b][1,4]-oxazin-3(4H)-ones using Smiles rearrangement and their in vitro evaluation as platelet aggregation inhibitors.
Xia S; Liu JQ; Wang XH; Tian Y; Wang Y; Wang JH; Fang L; Zuo H
Bioorg Med Chem Lett; 2014 Mar; 24(6):1479-83. PubMed ID: 24565904
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, identification and antiplatelet evaluation of 2-morpholino substituted benzoxazines.
Pritchard KM; Al-Rawi J; Bradley C
Eur J Med Chem; 2007 Sep; 42(9):1200-10. PubMed ID: 17336427
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
Yang J; Hua WY; Wang FX; Wang ZY; Wang X
Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 8-aryl-2-morpholino-7-O-substituted benzo[e][1,3]oxazin-4-ones against DNA-PK, PI3K, PDE3A enzymes and platelet aggregation.
Saifuzzaman M; Morrison R; Zheng Z; Orive S; Hamilton J; Thompson PE; Al-Rawi JMA
Bioorg Med Chem; 2017 Oct; 25(20):5531-5536. PubMed ID: 28838830
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
Yao FM; Sun CS
Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structural elucidation and DNA-dependant protein kinase and antiplatelet studies of 2-amino-[5, 6, 7, 8-mono and 7, 8-di-substituted]-1,3-benzoxazines.
Ihmaid S; Al-Rawi J; Bradley C
Eur J Med Chem; 2010 Nov; 45(11):4934-46. PubMed ID: 20800933
[TBL] [Abstract][Full Text] [Related]
12. 1,4-Benzoxazine-3(4H)-ones as potent inhibitors of platelet aggregation: design, synthesis and structure-activity relations.
Liu C; Tan JL; Xiao SY; Liao JF; Zou GR; Ai XX; Chen JB; Xiang Y; Yang Q; Zuo H
Chem Pharm Bull (Tokyo); 2014; 62(9):915-20. PubMed ID: 25007750
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents.
Huang WH; Lee AR; Chien PY; Chou TC
J Pharm Pharmacol; 2005 Feb; 57(2):219-25. PubMed ID: 15720786
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis of ferulic acid derivatives and their inhibitory effect on platelet aggregation].
Li JM; Zhao YH; Zhong GC; Long ZJ; Zhou P; Yuan M
Yao Xue Xue Bao; 2011 Mar; 46(3):305-10. PubMed ID: 21626785
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 6-cinnamoyl-2H-benzo[b][1,4]oxazin-3(4H)-ones and their effects on A549 lung cancer cell growth.
Zhou XW; Ma HL; Zhang X; Jing SY; Miao JY; Zhao BX
Eur J Med Chem; 2014 May; 79():95-101. PubMed ID: 24727462
[TBL] [Abstract][Full Text] [Related]
16. The evaluation and structure-activity relationships of 2-benzoylaminobenzoic esters and their analogues as anti-inflammatory and anti-platelet aggregation agents.
Hsieh PW; Hwang TL; Wu CC; Chiang SZ; Wu CI; Wu YC
Bioorg Med Chem Lett; 2007 Mar; 17(6):1812-7. PubMed ID: 17197180
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro activities on anti-platelet aggregation of 4-methoxybenzene-1,3-isophthalamides.
Liu XJ; Shi XX; Zhong YL; Liu N; Liu K
Bioorg Med Chem Lett; 2012 Nov; 22(21):6591-5. PubMed ID: 23010272
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-platelet activity of obovatol derivatives.
Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK
Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one scaffold. A systematic study.
Anderluh M; Cesar J; Stefanic P; Kikelj D; Janes D; Murn J; Nadrah K; Tominc M; Addicks E; Giannis A; Stegnar M; Dolenc MS
Eur J Med Chem; 2005 Jan; 40(1):25-49. PubMed ID: 15642407
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of platelet aggregation inhibitory activity of some 3-phenyl-pyrroloquinazolinones.
Ferlin MG; Borgo C; Deana R
Eur J Med Chem; 2012 Feb; 48():275-83. PubMed ID: 22236469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
